Monday, 2 December 2019

Biocon climbs 5% on launch of Ogivri biosimilar in US market

Ogivri is used to treat breast cancer and gastric cancer and Biocon has regulatory approval to sell it in more than 80 countries worldwide.

from Markets https://ift.tt/34JWvEa

No comments:

Post a Comment

Goldprice dips Rs 10 to Rs 62,720, silver falls Rs 100 to Rs 74,900

The price of 22-carat gold also fell Rs 10 with the yellow metal selling at Rs 57,490 from Markets https://ift.tt/rpZGNwM